Clinical Psychopharmacology:
A Master Class

Ross Baldessarini, MD, DSc (hon.)

July 13 – 15, 2018 • Friday – Sunday

See Accreditation


This seminar will address recent clinical research that forms the basis of rational, evidence-based clinical practice in the care of patients with bipolar disorder, major depression, schizophrenia, other psychotic disorders, and severe anxiety disorders. It will emphasize and critically address the evidence base that guides clinical practice in the use of psychotropic medicines to these disorders, considering short-term and long-term efficacy and dosing of antipsychotic, moodstabilizing, antidepressant drugs, and anti-anxiety agents as well as their adverse-effect risks. Participants are expected to be experienced clinicians (psychiatrists, other physicians, nurse practitioners, psychologists, social workers) with curiosity about the procedures and findings of modern clinical and experimental therapeutics research as a sound basis for improved clinical practice. Educational presentation will be in seminar format and include lectures, participant discussion and Q&A.


Upon completion of this seminar, participants will be able to:


  • Describe and critically evaluate the evolution of clinical psychopharmacology over the past halfcentury, its current status, and future prospects;
  • Evaluate evidence supporting short- and long-term treatment of patients with schizophrenia and other psychotic disorders;
  • Evaluate evidence supporting short- and long-term treatment of patients with bipolar disorder;
  • Describe and critically evaluate evidence supporting short- and long-term treatment of patients with major depressive disorder and severe anxiety disorders;
  • Analyze current relationships between treatment with psychotropic drugs and risk of mortality due to suicide and other causes of increased mortality risks in psychiatric patients;
  • Assess potentially severe adverse effects of psychotropic drug treatment;
  • Improve skills in avoiding, limiting and managing risk of adverse effects of psychotropic drug treatment;
  • Evaluate treatment practices involving psychotropic drugs and develop strategies to improve clinical practice;
  • Better integrate psychopharmacology into the comprehensive care of patients;
  • Critically assess advantages and limitations of clinical psychopharmacology;
  • Critically assess the impact of clinical psychopharmacology on theory, training, research, and practice of contemporary clinical mental health professional.




Friday, July 13, 2018

Friday Session: 4:30-6:30pm

Overview & update on modern psychopharmacology: historical development, clinical research methods, and clinical applications of major research findings.

Evidence for the efficacy and effectiveness of antipsychotic drugs; comparisons of modern and first-generation agents.

Discussion & questions.


Saturday, July 14, 2018

Saturday Session: 8:15-12:30pm ( Break 10:15-10:30am)

Evidence for the efficacy and effectiveness of treatments for acute mania and recurrences of mania, bipolar depression and mixed manic-depressive states.

Discussion & questions.

Comparisons of lithium, anticonvulsants and antipsychotics for treatment of bipolar disorder patients.

Introduction to the pharmacology and short-term clinical use of antidepressants for major depressive and anxiety disorders.

Discussion & questions.


Sunday, July 15, 2018

Sunday Session: 8:15-12:30pm ( Break 10:15-10:30am)

Long-term use of antidepressants to treat depression and anxiety disorders; managing treatment-resistant depression.

Effects of treatment on suicidal risks and overall mortality risks.

Discussion & questions.

Practical aspects of clinical use of psychotropic drugs; discussion of the current status of clinical psychopharmacology with respect to research, training, and clinical practice.

General discussion.